284462-80-2 Usage
Description
4-(2-Carbamoyl-pyridin-4-yloxy)aniline is a chemical compound with the molecular formula C14H13N3O2. It is a derivative of aniline and contains a carbamoyl-pyridin-4-yloxy group. 4-(2-Carbamoyl-pyridin-4-yloxy)aniline has potential applications in various fields, including medicinal chemistry, materials science, and chemical synthesis.
Uses
Used in Medicinal Chemistry:
4-(2-Carbamoyl-pyridin-4-yloxy)aniline is used as a building block for drug discovery and development. Its unique structure and functional groups make it a promising candidate for the design and synthesis of new pharmaceutical compounds.
Used in Materials Science:
4-(2-Carbamoyl-pyridin-4-yloxy)aniline may have potential applications in materials science, such as in the development of new materials with specific properties or functions. Its chemical structure and reactivity could be utilized to create novel materials with improved performance.
Used in Chemical Synthesis:
4-(2-Carbamoyl-pyridin-4-yloxy)aniline can be used as an intermediate or reactant in various chemical synthesis processes. Its versatility and reactivity make it a valuable component in the synthesis of other complex organic compounds.
Further research and testing are required to fully understand the properties and potential applications of 4-(2-Carbamoyl-pyridin-4-yloxy)aniline. Its unique structure and functional groups offer exciting opportunities for exploration and innovation in various scientific and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 284462-80-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,4,6 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 284462-80:
(8*2)+(7*8)+(6*4)+(5*4)+(4*6)+(3*2)+(2*8)+(1*0)=162
162 % 10 = 2
So 284462-80-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H11N3O2/c13-8-1-3-9(4-2-8)17-10-5-6-15-11(7-10)12(14)16/h1-7H,13H2,(H2,14,16)
284462-80-2Relevant articles and documents
ARYL UREAS WITH ANGIOGENISIS INHIBITING ACTIVITY
-
, (2016/02/12)
This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
DIARYL UREAS AND COMBINATIONS
-
Page/Page column 45, (2008/06/13)
The present invention provides methods for treating cancer in humans and other mammals comprising administering a chemotherapeutic agent, such as an interferon, and an aryl urea compound of Formula (I) : B-NH-C(O)-NH-L-M-L1-(Q)1-3 (I). In Formula (I), B and L and are each, independently, optionally substituted phenyl, naphthyl, a 5 or 6 membered monocyclic heteroaryl group, or an 8 to 10 membered bicyclic heteroaryl group; M is a bridging group. Each Q is independently C(O)R4, C(O)OR4 and C(O)NR4R5; and L' is optionally substituted phenyl, naphthyl, monocyclic heteroaryl or bicyclic heteroaryl, or a saturated or partially saturated, monocyclic or bicyclic carbocyclic moiety or heterocyclic moiety.
TREATMENT OF CANCERS WITH ACQUIRED RESISTANCE TO KIT INHIBITORS
-
Page/Page column 11-12, (2012/04/23)
The present invention provides compositions and methods for treating cancers ; which have acquired resistance to a KIT inhibitor by administering effective amounts of sorafenib.
